Case details

Court: ded
Docket #: 1:15-cv-00880
Case Name: Salix Pharmaceuticals, Inc. et al v. Apotex, Inc. et al
PACER case #: 57924
Date filed: 2015-09-30
Date terminated: 2016-05-18
Assigned to: Judge Gregory M. Sleet
Case Cause: 35:271 Patent Infringement
Nature of Suit: 830 Patent
Jury Demand: Defendant
Jurisdiction: Federal Question

Parties

Represented Party Attorney & Contact Info
Salix Pharmaceuticals, Inc.
Counter Defendant
 
Jack B. Blumenfeld
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Bruce M. Wexler
(See above for address)
ATTORNEY TO BE NOTICED

Jennifer T. Nguyen
(See above for address)
ATTORNEY TO BE NOTICED

Maryellen Noreika
(See above for address)
ATTORNEY TO BE NOTICED

Melanie R. Rupert
(See above for address)
ATTORNEY TO BE NOTICED
Glycyx Pharmaceuticals, Ltd.
Counter Defendant
 
Jack B. Blumenfeld
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Maryellen Noreika
(See above for address)
ATTORNEY TO BE NOTICED
Valeant Pharmaceuticals International
Counter Defendant
 
Jack B. Blumenfeld
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Maryellen Noreika
(See above for address)
ATTORNEY TO BE NOTICED
Valeant Pharmaceuticals Luxembourg S.A.R.L.
Counter Defendant
 
Jack B. Blumenfeld
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Maryellen Noreika
(See above for address)
ATTORNEY TO BE NOTICED
Apotex Inc.
Counter Claimant
 
Kelly E. Farnan
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Christine Dealy Haynes
(See above for address)
ATTORNEY TO BE NOTICED
Apotex Corp.
Counter Claimant
 
Kelly E. Farnan
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Christine Dealy Haynes
(See above for address)
ATTORNEY TO BE NOTICED

Documents

Date Filed Document # Attachment # Short Description Long Description Upload date SHA1 hash
2015-09-30 1 0 COMPLAINT for PATENT INFRINGEMENT filed against Apotex Corp., Apotex, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1797926.) - filed by Salix Pharmaceuticals, Inc., Glycyx Pharmaceuticals, Ltd., Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L.. (Attachments: # 1 Exhibit A and B, # 2 Civil Cover Sheet)(nmb) (Entered: 10/01/2015)
2015-09-30 2 0 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 10/01/2015)
2015-09-30 3 0 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/19/15. Date of Expiration of Patent: 3/13/18, 6/23/31.Thirty Month Stay Deadline: 2/19/2018. (nmb) (Entered: 10/01/2015)
2015-09-30 4 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,197,341 B1; 8,497,256 B2. (nmb) (Entered: 10/01/2015)
2015-09-30 5 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Valeant Pharmaceuticals International, Corporate Parent Valeant Pharmaceuticals International, Inc., Corporate Parent Salix Pharmaceuticals, Ltd., Corporate Parent Biovail Americas Corp., Corporate Parent V-BAC Holdings Corp., Corporate Parent Valeant Canada LP. for Salix Pharmaceuticals, Inc. filed by Salix Pharmaceuticals, Inc.. (nmb) (Entered: 10/01/2015)
2015-09-30 6 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Valeant Pharmaceuticals International, Corporate Parent Valeant Pharmaceuticals International, Inc., Corporate Parent Salix Pharmaceuticals Ltd., Corporate Parent Biovail Americas Corp., Corporate Parent V-BAC Holdings Corp., Corporate Parent Valeant Canada LP. for Glycyx Pharmaceuticals, Ltd. filed by Glycyx Pharmaceuticals, Ltd.. (nmb) (Entered: 10/01/2015)
2015-09-30 7 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Valeant Pharmaceuticals International, Inc., Corporate Parent Biovail Americas Corp., Corporate Parent V-BAC Holdings Corp., Corporate Parent Valeant Canada LP. for Valeant Pharmaceuticals International filed by Valeant Pharmaceuticals International. (nmb) (Entered: 10/01/2015)
2015-09-30 8 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Valeant Pharmaceuticals International, Inc., Corporate Parent Valeant Holdings Ireland, Corporate Parent Valeant International Luxembourg S.a.r.l for Valeant Pharmaceuticals Luxembourg S.A.R.L. filed by Valeant Pharmaceuticals Luxembourg S.A.R.L.. (nmb) (Entered: 10/01/2015)
2015-11-04 9 0 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Melanie R. Rupert, and Jennifer T. Nguyen - filed by Glycyx Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L.. (Noreika, Maryellen) (Entered: 11/04/2015)
2015-12-22 10 0 SUMMONS Returned Executed by Salix Pharmaceuticals, Inc., Glycyx Pharmaceuticals, Ltd., Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L.. Apotex Corp. served on 12/22/2015, answer due 1/12/2016. (Noreika, Maryellen) (Entered: 12/22/2015)
2015-12-22 11 0 SUMMONS Returned Executed by Salix Pharmaceuticals, Inc., Glycyx Pharmaceuticals, Ltd., Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L.. Apotex Inc. served on 12/22/2015, answer due 1/12/2016. (Noreika, Maryellen) (Entered: 12/22/2015)
2016-01-08 12 0 STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to and including February 12, 2016 - filed by Apotex Corp., Apotex Inc.. (Farnan, Kelly) (Entered: 01/08/2016)
2016-01-13 13 0 MOTION for Pro Hac Vice Appearance of Attorney Steven E. Feldman, Daniel R. Cherry and Sherry L. Rollo of Hahn Loeser & Parks LLP - filed by Apotex Corp., Apotex Inc.. (Farnan, Kelly) (Entered: 01/13/2016)
2016-02-08 14 0 Second STIPULATION TO EXTEND TIME to Answer the Complaint March 14, 2016 to March 14, 2016 - filed by Apotex Corp., Apotex Inc.. (Haynes, Christine) (Entered: 02/08/2016)
2016-03-14 15 0 ANSWER to 1 Complaint, with Jury Demand , COUNTERCLAIM against Glycyx Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L. by Apotex Inc., Apotex Corp.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Kelly) (Entered: 03/14/2016)
2016-03-14 16 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,452,872 B2; 7,625,884 B2; . (Farnan, Kelly) (Entered: 03/14/2016)
2016-03-14 17 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings, Inc. for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Farnan, Kelly) (Entered: 03/14/2016)
2016-03-14 18 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Farnan, Kelly) (Entered: 03/14/2016)
2016-03-15 19 0 ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 3/15/2016. (asw) (Entered: 03/15/2016)
2016-04-07 20 0 ANSWER to 15 Answer to Complaint,, Counterclaim, by Glycyx Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L..(Noreika, Maryellen) (Entered: 04/07/2016)
2016-04-13 21 0 STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report to April 27, 2016 - filed by Glycyx Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L.. (Blumenfeld, Jack) (Entered: 04/13/2016)
2016-04-26 22 0 STIPULATION TO EXTEND TIME to submit Joint Status Report to May 27, 2016 - filed by Apotex Corp., Apotex Inc.. (Haynes, Christine) (Entered: 04/26/2016)
2016-05-05 23 0 NOTICE of Change of Address by Maryellen Noreika (Noreika, Maryellen) (Entered: 05/05/2016)
2016-05-13 24 0 STIPULATION of Dismissal without Prejudice by Glycyx Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L.. (Noreika, Maryellen) Modified on 5/13/2016 (mdb). (Entered: 05/13/2016)
2016-05-18 25 0 SO ORDERED - re 24 Stipulation of Dismissal without Prejudice. Signed by Judge Gregory M. Sleet on 5/18/2016. ***Civil Case Terminated*** (mdb) (Entered: 05/18/2016)
2016-05-18 26 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) (Entered: 05/18/2016)